Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001214659-21-007477
Filing Date
2021-07-13
Accepted
2021-07-13 17:01:08
Documents
12
Effectiveness Date
2021-07-13

Document Format Files

Seq Description Document Type Size
1 j712211s8.htm S-8 234593
2 EXHIBIT 4.3 ex4_3.htm EX-4.3 7842
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 9458
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 2791
5 EXHIBIT 99.1 ex99_1.htm EX-99.1 112104
6 EXHIBIT 99.2 ex99_2.htm EX-99.2 128824
7 EXHIBIT 99.3 ex99_3.htm EX-99.3 34155
8 EXHIBIT 99.4 ex99_4.htm EX-99.4 29175
9 GRAPHIC alzamendlogo.jpg GRAPHIC 17195
10 GRAPHIC ex4_31.jpg GRAPHIC 154329
11 GRAPHIC olshan_footer.jpg GRAPHIC 7271
12 GRAPHIC olshan_header.jpg GRAPHIC 11305
  Complete submission text file 0001214659-21-007477.txt   822329
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-8 | Act: 33 | File No.: 333-257873 | Film No.: 211088517
SIC: 2834 Pharmaceutical Preparations